FluroTech (TSXV:TEST), (“FluroTech” or the “Company”), has successfully completed the development of the test kits for THCa and CBDa. When used with the Company’s flagship quality control and potency optimization testing device, the CompleTest™, accurate, reliable and consistent THCa and CBDa testing results can be achieved onsite within 15 minutes with this user friendly solution.

By having onsite cannabis testing, companies can save the time of shipping samples to the lab, improve the accuracy of labeling and cannabis sorting, pre-validate lab testing results, and optimize potency yield and cannabis curing techniques by testing the cannabis multiple times during the production process.


“FluroTech’s science team has developed a straightforward testing protocol to accurately measure the concentrations of THCa and CBDa. Each test can be done with as little as 0.10 grams of cannabis,” commented Dr. Elmar Prenner, Chief Technology Officer. “I am not aware of any other affordable technology that can achieve the same degree of accuracy without the use of trained lab technicians and relatively expensive lab equipment.”

In preliminary data comparisons for the test for THCa and CBDa, the CompleTest™ results were very close to the results obtained for the same test sample by the current industry standard equipment, High Performance Liquid Chromatography or mass spectrometry. Unlike, the current testing equipment which often requires more data interpretation by scientists which may lead to cross-lab variability, CompleTest™ yielded the same test results on multiple test samples in a row.

The Company expects to obtain independent, third party validation of the THCa and CBDa test kits and the CompleTest™ device in the month of September and allow beta users to provide feedback prior to commercialization in late October.

“This milestone is significant for the Company. I believe that, it advances FluroTech from a research and development company to a position of achieving commercialization. In addition to the now completed heavy metals tests, the test for THCa and CBDa represents the completion of the second of seven prospective revenue streams the Company is actively developing” says CEO, Danny Dalla-Longa.

About CompleTest™

CompleTest™ is FluroTech’s flagship brand and product line. CompleTest™ is a portable, cost-effective, state-of-the-art cannabis testing device, able to provide quick, accurate and consistent testing results. It is designed for cultivators, dispensaries and anyone with a vested interest in consumer safety to test the quality and safety of their cannabis products and to optimize potency yield.

About FluroTech (TSX-V: TEST)

FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech‘s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using the technology that was developed at the University of Calgary in conjunction with the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits.

To learn more, visit www.FluroTech.com and watch our video.

Contact Information

FluroTech Ltd.
Alistair Ross Technology Centre
Suite 111, 3553-31 Street NW
Calgary, AB T2L 2K7
info@flurotech.com

Danny Dalla-Longa
Chief Executive Officer
403.680.0644
danny@flurotech.com

Prit Singh
IR — Thesis Capital Inc.
905.510.7636
psingh@thesiscapital.ca

Source: www.newsfilecorp.com

Ensuring estoraTMpatients have seamless access to their high-quality medical cannabis products

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announce that its subsidiary Pineapple Express Delivery Inc. (“Pineapple Express Delivery” or “PED”), a leading logistics technology company offering compliant and secure delivery of controlled substances and regulated products, has partnered with CannTrust Inc. to bring same-day and next-day delivery to estoraTM medical cannabis patients in Ontario

Keep reading... Show less

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less